| Monoamine oxidase B inhibitor, selegiline, reduces 18F-THK5351 uptake in the human brain KP Ng, TA Pascoal, S Mathotaarachchi, J Therriault, MS Kang, M Shin, ... Alzheimer's research & therapy 9, 1-9, 2017 | 340 | 2017 |
| In vivo quantification of neurofibrillary tangles with [18F]MK-6240 TA Pascoal, M Shin, MS Kang, M Chamoun, D Chartrand, ... Alzheimer's research & therapy 10, 1-14, 2018 | 153 | 2018 |
| Neuropsychiatric symptoms predict hypometabolism in preclinical Alzheimer disease KP Ng, TA Pascoal, S Mathotaarachchi, CO Chung, AL Benedet, M Shin, ... Neurology 88 (19), 1814-1821, 2017 | 83 | 2017 |
| Cerebrospinal fluid synaptosomal-associated protein 25 is a key player in synaptic degeneration in mild cognitive impairment and Alzheimer’s disease H Zhang, J Therriault, MS Kang, KP Ng, TA Pascoal, P Rosa-Neto, ... Alzheimer's research & therapy 10, 1-11, 2018 | 79 | 2018 |
| Anosognosia predicts default mode network hypometabolism and clinical progression to dementia J Therriault, KP Ng, TA Pascoal, S Mathotaarachchi, MS Kang, H Struyfs, ... Neurology 90 (11), e932-e939, 2018 | 66 | 2018 |
| Cerebrospinal fluid phosphorylated tau, visinin-like protein-1, and chitinase-3-like protein 1 in mild cognitive impairment and Alzheimer’s disease H Zhang, KP Ng, J Therriault, MS Kang, TA Pascoal, P Rosa-Neto, ... Translational neurodegeneration 7, 1-12, 2018 | 48 | 2018 |
| Impact of the biological definition of Alzheimer’s disease using amyloid, tau and neurodegeneration (ATN): what about the role of vascular changes, inflammation, Lewy body … S Gauthier, H Zhang, KP Ng, TA Pascoal, P Rosa-Neto Translational neurodegeneration 7, 1-7, 2018 | 45 | 2018 |
| The influence of language and culture on cognitive assessment tools in the diagnosis of early cognitive impairment and dementia KP Ng, HJ Chiew, L Lim, P Rosa-Neto, N Kandiah, S Gauthier Expert review of neurotherapeutics 18 (11), 859-869, 2018 | 44 | 2018 |
| Associations of AT (N) biomarkers with neuropsychiatric symptoms in preclinical Alzheimer’s disease and cognitively unimpaired individuals KP Ng, H Chiew, P Rosa-Neto, N Kandiah, Z Ismail, S Gauthier Translational Neurodegeneration 10, 1-14, 2021 | 40 | 2021 |
| Agitation and impulsivity in mid and late life as possible risk markers for incident dementia DR Bateman, S Gill, S Hu, ED Foster, MT Ruthirakuhan, AF Sellek, ... Alzheimer's & Dementia: Translational Research & Clinical Interventions 6 (1 …, 2020 | 34 | 2020 |
| Associations between lesions and domain-specific cognitive decline in poststroke dementia C Yatawara, KP Ng, R Chander, N Kandiah Neurology 91 (1), e45-e54, 2018 | 29 | 2018 |
| Cerebral small vessel disease influences hippocampal subfield atrophy in mild cognitive impairment FCC Wong, C Yatawara, A Low, H Foo, BYX Wong, L Lim, B Wang, ... Translational Stroke Research 12, 284-292, 2021 | 28 | 2021 |
| Brain metabolic dysfunction in early neuropsychiatric symptoms of dementia KP Ng, HJ Chiew, P Rosa-Neto, N Kandiah, Z Ismail, S Gauthier Frontiers in Pharmacology 10, 1398, 2019 | 28 | 2019 |
| Age moderates associations of hypertension, white matter hyperintensities, and cognition AC Guevarra, SC Ng, SE Saffari, BYX Wong, RJ Chander, KP Ng, ... Journal of Alzheimer's Disease 75 (4), 1351-1360, 2020 | 27 | 2020 |
| Is ApoE ɛ 4 a good biomarker for amyloid pathology in late onset Alzheimer’s disease? M Ba, M Kong, X Li, KP Ng, P Rosa-Neto, S Gauthier Translational Neurodegeneration 5, 1-4, 2016 | 26 | 2016 |
| Enhanced supervised descent learning technique for electromagnetic inverse scattering problems by the deep convolutional neural networks HM Yao, R Guo, M Li, L Jiang, MKP Ng IEEE Transactions on Antennas and Propagation 70 (8), 6195-6206, 2022 | 25 | 2022 |
| Neuroimaging in dementias S Mahalingam, MK Chen Seminars in Neurology 39 (02), 188-199, 2019 | 25 | 2019 |
| Rasagiline, a monoamine oxidase B inhibitor, reduces in vivo [18F] THK5351 uptake in progressive supranuclear palsy KP Ng, J Therriault, MS Kang, H Struyfs, TA Pascoal, S Mathotaarachchi, ... NeuroImage: Clinical 24, 102091, 2019 | 25 | 2019 |
| The use of tau PET to stage Alzheimer disease according to the Braak staging framework AC Macedo, C Tissot, J Therriault, S Servaes, YT Wang, ... Journal of Nuclear Medicine 64 (8), 1171-1178, 2023 | 20 | 2023 |
| The prevalence and biomarkers’ characteristic of rapidly progressive Alzheimer's disease from the Alzheimer's Disease Neuroimaging Initiative database M Ba, X Li, KP Ng, TA Pascoal, S Mathotaarachchi, P Rosa-Neto, ... Alzheimer's & Dementia: Translational Research & Clinical Interventions 3 (1 …, 2017 | 20 | 2017 |
